Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2101.85-40.2 (-1.88 % )
PREV CLOSE (Rs.) 2142.05
OPEN PRICE (Rs.) 2141.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5356
TODAY'S LOW / HIGH (Rs.)2084.15 2159.00
52 WK LOW / HIGH (Rs.)1768.55 2455.55
NSE2104.40 -37.9 (-1.77 % )
PREV CLOSE(Rs.) 2142.30
OPEN PRICE (Rs.) 2159.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2104.40 (998 )
VOLUME 98862
TODAY'S LOW / HIGH(Rs.) 2084.00 2163.60
52 WK LOW / HIGH (Rs.)1749.9 2460

Company Profile

Financial ratio

Particulars Mar  2020 Mar  2019 Mar  2018 Mar  2017 Mar  2016
Operational & Financial Ratios          
   Earnings Per Share (Rs) 47.92 35.27 18.97 15.42 7.38
   CEPS(Rs) 65.05 49.58 33.39 29.77 20.56
   DPS(Rs) 5.00 3.00 1.00 1.00 0.00
   Book NAV/Share(Rs) 286.15 247.12 213.02 194.55 179.02
   Tax Rate(%) 18.12 19.01 17.34 24.98 17.52
Margin Ratios          
   Core EBITDA Margin(%) 19.16 17.98 13.46 12.93 9.42
   EBIT Margin(%) 16.49 15.12 9.82 9.25 5.20
   Pre Tax Margin(%) 16.06 14.53 8.98 8.42 4.01
   PAT Margin (%) 13.15 11.77 7.42 6.31 3.31
   Cash Profit Margin (%) 17.68 16.60 12.83 11.70 8.93
Performance Ratios          
   ROA(%) 12.47 10.25 6.03 5.17 2.50
   ROE(%) 18.15 15.28 9.47 8.60 4.31
   ROCE(%) 19.92 16.53 9.94 9.44 4.82
   Asset Turnover(x) 0.95 0.87 0.81 0.82 0.75
   Sales/Fixed Asset(x) 1.64 1.48 1.37 1.43 1.23
   Working Capital/Sales(x) 3.04 2.95 3.50 4.09 4.46
Efficiency Ratios          
   Fixed Capital/Sales(x) 0.61 0.68 0.73 0.70 0.81
   Receivable days 61.90 62.09 61.27 53.75 50.16
   Inventory Days 94.05 94.47 97.98 97.70 110.76
   Payable days 49.85 51.13 50.35 52.23 52.92
Valuation Parameters          
   PER(x) 28.97 27.86 34.52 40.44 78.55
   PCE(x) 21.34 19.82 19.61 20.94 28.20
   Price/Book(x) 4.85 3.98 3.07 3.20 3.24
   Yield(%) 0.36 0.31 0.15 0.16 0.00
   EV/Net Sales(x) 3.86 3.36 2.68 2.71 2.79
   EV/Core EBITDA(x) 18.26 16.73 17.48 18.18 25.47
   EV/EBIT(x) 23.27 22.08 27.12 28.75 52.96
   EV/CE(x) 3.39 2.77 2.12 2.16 2.06
   M Cap / Sales 3.80 3.31 2.54 2.49 2.55
Growth Ratio          
   Net Sales Growth(%) 23.32 14.98 3.22 10.08 -8.82
   Core EBITDA Growth(%) 29.76 50.57 6.36 49.52 -45.10
   EBIT Growth(%) 34.35 77.00 8.44 96.58 -61.55
   PAT Growth(%) 37.69 82.24 20.14 110.81 -62.88
   EPS Growth(%) 35.88 85.89 23.07 108.87 -63.36
Financial Stability Ratios          
   Total Debt/Equity(x) 0.13 0.15 0.23 0.29 0.38
   Current Ratio(x) 2.15 2.17 1.93 1.82 1.67
   Quick Ratio(x) 1.16 1.19 1.06 0.90 0.81
   Interest Cover(x) 38.77 25.65 11.69 11.05 4.38
   Total Debt/Mcap(x) 0.03 0.04 0.08 0.09 0.12